LU85812A1 - Forme dosee d'etoposide a usage oral - Google Patents

Forme dosee d'etoposide a usage oral Download PDF

Info

Publication number
LU85812A1
LU85812A1 LU85812A LU85812A LU85812A1 LU 85812 A1 LU85812 A1 LU 85812A1 LU 85812 A LU85812 A LU 85812A LU 85812 A LU85812 A LU 85812A LU 85812 A1 LU85812 A1 LU 85812A1
Authority
LU
Luxembourg
Prior art keywords
etoposide
weight
composition according
acid
water
Prior art date
Application number
LU85812A
Other languages
English (en)
French (fr)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of LU85812A1 publication Critical patent/LU85812A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
LU85812A 1984-03-19 1985-03-18 Forme dosee d'etoposide a usage oral LU85812A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59114484A 1984-03-19 1984-03-19
US59114484 1984-03-19

Publications (1)

Publication Number Publication Date
LU85812A1 true LU85812A1 (fr) 1985-12-12

Family

ID=24365235

Family Applications (1)

Application Number Title Priority Date Filing Date
LU85812A LU85812A1 (fr) 1984-03-19 1985-03-18 Forme dosee d'etoposide a usage oral

Country Status (28)

Country Link
JP (1) JPS60209516A (no)
KR (1) KR850006136A (no)
AT (1) AT392904B (no)
AU (1) AU571308B2 (no)
BE (1) BE901963A (no)
CA (1) CA1238578A (no)
CH (1) CH662731A5 (no)
DE (1) DE3509741A1 (no)
DK (1) DK164535C (no)
EG (1) EG17521A (no)
ES (1) ES8702140A1 (no)
FI (1) FI84023C (no)
FR (1) FR2561104B1 (no)
GB (1) GB2155789B (no)
GR (1) GR850688B (no)
IE (1) IE58340B1 (no)
IL (1) IL74615A (no)
IT (1) IT1187640B (no)
LU (1) LU85812A1 (no)
MY (1) MY101916A (no)
NL (1) NL8500739A (no)
NO (1) NO170569C (no)
NZ (1) NZ211078A (no)
OA (1) OA07968A (no)
PT (1) PT80131B (no)
SE (1) SE8501312L (no)
YU (1) YU45243B (no)
ZA (1) ZA851935B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60239418A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド軟カプセル製剤
JPS61189230A (ja) * 1985-02-19 1986-08-22 Nippon Kayaku Co Ltd エトポシド製剤
DE3629386A1 (de) * 1986-08-29 1988-03-03 Scherer Gmbh R P Gelatinekapseln und verfahren zu ihrer herstellung
US4927638A (en) * 1986-10-08 1990-05-22 Bristol-Myers Company Etoposide solutions
US5154930A (en) * 1987-03-05 1992-10-13 The Liposome Company, Inc. Pharmacological agent-lipid solution preparation
US5376381A (en) * 1988-02-25 1994-12-27 The Liposome Company, Inc. Integrity protected gelatin
JP2000247911A (ja) * 1999-02-26 2000-09-12 Hisamitsu Pharmaceut Co Inc 大腸用吸収促進剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH580255A5 (no) * 1974-06-04 1976-09-30 Calinter Sa
DE2452785A1 (de) * 1974-11-07 1976-05-13 Universal Oil Prod Co Verfahren zum betrieb einer verbrennungsmaschine
FR2358144A1 (fr) * 1976-07-13 1978-02-10 Lipha Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire
JPS5940137B2 (ja) * 1976-10-14 1984-09-28 武田薬品工業株式会社 経口投与用医薬組成物
FR2410504A1 (fr) * 1977-12-05 1979-06-29 Air Liquide Procede de reglage de securite d'un reacteur chimique et installation de reaction d'oxydation mettant en oeuvre ce procede
DE2809543A1 (de) * 1978-03-06 1979-09-13 Werner Henke Verfahren und vorrichtung zum neutralisieren von gasen bei oel- und gasbohrungen
JPS60239418A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド軟カプセル製剤

Also Published As

Publication number Publication date
NO851022L (no) 1985-09-20
IL74615A (en) 1988-07-31
DK122285D0 (da) 1985-03-18
DK122285A (da) 1985-09-20
NO170569B (no) 1992-07-27
GB8506943D0 (en) 1985-04-24
JPS60209516A (ja) 1985-10-22
IT1187640B (it) 1987-12-23
IT8519897A0 (it) 1985-03-14
PT80131A (en) 1985-04-01
PT80131B (pt) 1987-10-20
GB2155789B (en) 1987-10-21
AT392904B (de) 1991-07-10
NZ211078A (en) 1987-08-31
DK164535C (da) 1992-11-30
ZA851935B (en) 1985-10-30
FI851040A0 (fi) 1985-03-15
GB2155789A (en) 1985-10-02
FR2561104A1 (fr) 1985-09-20
NO170569C (no) 1992-11-04
SE8501312D0 (sv) 1985-03-18
FI84023B (fi) 1991-06-28
GR850688B (no) 1985-07-08
DE3509741A1 (de) 1985-09-26
SE8501312L (sv) 1985-09-20
ES541370A0 (es) 1986-12-16
FR2561104B1 (fr) 1988-04-08
ATA81985A (de) 1990-12-15
IE850686L (en) 1985-09-19
FI851040L (fi) 1985-09-20
FI84023C (fi) 1991-10-10
MY101916A (en) 1992-02-15
YU42085A (en) 1988-02-29
EG17521A (en) 1990-06-30
CH662731A5 (de) 1987-10-30
IL74615A0 (en) 1985-06-30
AU3897585A (en) 1985-09-26
NL8500739A (nl) 1985-10-16
AU571308B2 (en) 1988-04-14
ES8702140A1 (es) 1986-12-16
BE901963A (fr) 1985-09-18
YU45243B (en) 1992-05-28
IE58340B1 (en) 1993-09-08
OA07968A (fr) 1987-01-31
DK164535B (da) 1992-07-13
CA1238578A (en) 1988-06-28
KR850006136A (ko) 1985-10-02

Similar Documents

Publication Publication Date Title
CA2680433C (fr) Nouvelle composition a base d'oxime de cholest-4-en-3-one
RU2260428C2 (ru) Фармацевтическая композиция, содержащая производное бензамида и обладающая повышенной растворимостью и поглощаемостью при оральном применении
CA2231342C (fr) Composition pharmaceutique pour administration par voie orale
BE1015217A5 (no)
WO1993000928A1 (fr) Nouvelles compositions a base de derives de la classe des taxanes
FR2737121A1 (fr) Nouvelles formulations galeniques du fenofibrate et leurs applications
RU2708254C2 (ru) Пероральная композиция целекоксиба для лечения боли
JP2023027071A (ja) 二成分組成物
JP2009256216A (ja) 溶液状態で安定なアムロジピンベシル酸塩内服用液剤
LU85812A1 (fr) Forme dosee d'etoposide a usage oral
LU86901A1 (fr) Compositions pharmaceutiques de polypeptides adaptees a la resorption gastro-intestinale
EP1343473A1 (fr) Composition pharmaceutique de dronedarone pour administration parenterale
LU83363A1 (fr) Compositions antitumeurs
CN100584325C (zh) 一种含有薁磺酸钠与l-谷氨酰胺水溶性前体药物的组合物
EP1165042A1 (fr) Suspension pharmaceutique buvable d'ibuprofene
CN1919192A (zh) 莪术醇自乳化胶囊制剂及其制备方法
JPS5947202A (ja) 補酵素Ｑ↓１↓０のメチル化−β−シクロデキストリン包接体及びその製造方法
WO2019227746A1 (zh) 一种壳聚糖口服液及其制备方法
EP2600845B1 (fr) Composition pharmaceutique contenant un extrait de serenoa repens
KR100299942B1 (ko) 비페닐디메칠디카르복실레이트의액제
US20220184170A1 (en) Formulation to enhance the bioavailibity and stability of curcuminoids and/or its derivatives thereof
Goel et al. Pharmaceutical excipients
JPS6261568B2 (no)
WO2000059468A1 (fr) Suspension pharmaceutique buvable
WO2004047834A1 (en) Formulation and manufacturing process of solubilized aceclofenac soft capsules